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Emanuel Necas1Hematopoietic stem and progenitor cells (HSPC) for bone marrow transplantation are currently obtained
directly from living voluntary donors or from cord blood units. However, a suitable donor is not always found.
Because HSPC are known for their relative resistance to hypoxia, using an experimental murine model, we
explored cadaveric bone marrow (BM) as their alternative source. After donor mice were sacrificed, BM
was left in intact femurs at 37C, 20C, or 4C under ischemic conditions, resulting in combined oxygen
andmetabolic substrate shortage and the accumulation ofmetabolic waste products. BM cells were harvested
after a set time period ranging from 0 to 48 hours. To determine the impact of delayed harvesting on the trans-
plantability ofHSPC, a competitive repopulation assay using amurine Ly5.1/Ly5.2 congenicmodel in 2 different
settings was used: after submyeloablative (6 Gy) or myeloablative (9 Gy) total-body irradiation, Ly5.2 hosts
received cadaveric Ly5.1 cells or a mixture of cadaveric Ly5.1 cells and fresh Ly5.2 cells in a 1:1 ratio. Chime-
rism resulting from cadaveric donor cells, followed up to 6months after transplantation, proved that the long-
term repopulation ability of HSPC was fully preserved for 2 hours, 6 hours, and 12 hours at 37C, 20C, and
4C of ischemia, respectively. A colony-forming unit-spleen (CFU-S) clonogenic assay revealed a higher sen-
sitivity of proliferating hematopoietic progenitors to ischemia compared to repopulating cells (STRC and
LTRC). Flow cytometry analysis of apoptosis in cadaveric BMdemonstrated that the LSK (LinlowSca-11c-Kit1)
subpopulation, enriched in HSPC, contained less apoptotic and dead cells than the BM as a whole. Further-
more, the number of LSK SLAM (CD1501CD482) and LSK SP (side population) cells (fractions highly
enriched in hematopoietic stem cells) decreased in parallel with BM transplantability. As well as cadaveric
BM cells, we also tested the transplantability and survival of BM cells after storage in a suspension in vitrowith-
out specific hematopoietic growth factors. HSPC did not display any decrease in transplantability after 2 days
of storage at 37Cor 4 days at 4C.A higher sensitivity of progenitors to unfavorable conditionswas observed
again usingCFU-S and granulocytemacrophage-colony forming cell (GM-CFC) assays, especially at 37C. This
paper shows that HSPC survive the cessation of circulation for a considerable time andmaintain their engraft-
ment potential. This time is significantly extended with in vitro storage compared to the cadaveric BM.
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diseases. During the transplantation procedure, hema-
topoietic stem and progenitor cells (HSPC) obtained
from the BM of living donors are transplanted to mye-
loablated patients. The HSPC donor is usually a rela-
tive of the patient or an HLA-matched volunteer from
a registry [1]. Another source of HSPC is umbilical
cord blood, obtained during childbirth and preserved
in a cord blood unit [2]. Despite the international co-
operation between donor registries, in some cases suit-
able HSPC for transplantation are not found because
the patient has an unusual HLA-phenotype [1]. There-
fore, finding newways to enlarge the number of donors
remains a challenging task.
As was mentioned above, at present HSPC for
transplantation are harvested exclusively from living
donors or their source is cord blood. Nevertheless,1273
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gan donors and based on cell viability and colony-
forming unit (CFU) numbers, they assumed that the
cells could be procured with a high degree of engraft-
ment potential. In addition, a CD34-positive cell frac-
tion was not affected by storage for up to 3 days in
a heparinized RPMI 1640 medium at room tempera-
ture (20C) or in a refrigerator (4C-8C) [3]. Further-
more, BM cells harvested from cadaveric organ donors
and stored at 4C for 7 days did not display a significant
increase in apoptosis [4].
Organs for transplantation are routinely harvested
from non-heart-beating donors (NHBD) [5-7]. Four
categories of NHBD are identified: I (dead on arrival)
and II (unsuccessful resuscitation) are uncontrolled
donors; III (withdrawal of life-supporting therapy) and
IV (cardiac arrest in a brain-dead donor) are controlled
donors [8].Whereas the transplantability of solidorgans
fromNHBDand the tolerance of the organs towarm is-
chemiahas beenwidely studiedover the last twodecades
[5-7,9-11], practically no attention has been paid to the
BM, despite the fact that hematopoietic stem cells,
responsible for long-term repopulation, reside in
ahypoxicmicroenvironment of theBM, stemcell niches
[12,13]. Hypoxia, together with the cytokines produced
by the niche keep hematopoietic stem cells quiescent
[14-16], and this could favor their survival after the
cessation of circulation.
It can be assumed that these properties also enable
HSPC to survive in vitro, for instance, when they are
stored in a medium. Although the cells should be
used for BMT as soon as possible, sometimes this liq-
uid storage lasts for several hours or even days [17].
This can be because of harvesting being done via con-
secutive leukapheresis to collect a sufficient amount of
cells or because the cells need to be transported to the
patient, for example, to another country. The most
commonly used temperature for the storage of BM
cells or peripheral blood progenitor cells in a suspen-
sion is 4C to 8C, with the recommendation to not ex-
ceed 20C, and cells are usually transplanted within 72
hours after their initial collection.
In this study, we focused on the tolerance of mu-
rine HSPC, residing in their niches, to interruption
of the blood supply leading to anoxia and metabolic
starvation. The survival and transplantability of
HSPC collected from such cadaveric BM was com-
pared to those maintained in a tissue culture medium.
HSPC were analyzed by phenotyping, by clonal assays
and by competitive repopulation assay.MATERIALS AND METHODS
Animals
C57BL/6 mice (Ly5.2 and Ly5.1) were maintained
in a clean conventional animal facility with a light-darkcycle of 12 hours and fed ad libitum. Eight- to
12-week-old mice were used in the experiments. All
experiments were approved by the Laboratory Animal
Care and Use Committee of the First Faculty of Med-
icine, Charles University, and were performed in ac-
cordance with national and international guidelines
for laboratory animal care.
Cadaveric BM
Donor mice were sacrificed by cervical dislocation.
Intact femurs were removed and kept in preheated/
precooled phosphate-buffered saline (PBS) at 37C,
20C, and 4C, respectively, for various time periods
up to 48 hours. Subsequently, the ends of the femur
were opened and BM cells (‘‘cadaveric BM’’) were
flushed into a PBS with 0.5% bovine serum albumin
(BSA) solution (PBS/BSA further on) and kept on
ice. A single-cell suspension was prepared and the
number of nucleated cells was determined using an
AUTO T4 Cellometer (Nexelom Bioscience, Law-
rence, MA). Afterward, the survival and transplantabil-
ity of cadaveric BM cells was determined.
In Vitro Storage of BM Cells
Briefly, BM cells were harvested from the femurs
of sacrificed C57Bl/6 donors. Afterward, cells were
washed and resuspended in IMDM medium (Lonza
Biologics Inc., Portsmouth, NH) with 10% fetal calf
serum (FCS; Sigma Aldrich Corp., St. Louis, MO) at
a concentration of 10 106 cells/mL. Cells weremain-
tained in the medium for up to 10 days at 37C or 4C,
respectively. Subsequently, the survival of hematopoi-
etic progenitor cells was analyzed via the granulocyte-
macrophage-colony forming cells (GM-CFC) cultiva-
tionmethodand colony-formingunits-spleen (CFU-S)
method. Intervals of 1 and 2 days at 37C and 2 and
4days at 4Cwere also used for a competitive transplan-
tation repopulation assay.
Flow Cytometry Analysis of LSK SLAM and LSK
SP Cells
Fresh and cadaveric BM was analyzed by flow
cytometry for subpopulations enriched in stem
cells—the LSK SLAM [18] (LinlowSca-11c-Kit1
CD1501CD482) and LSK SP (LinlowSca-11c-Kit1,
side population,Hoechst 33342negative).TheSPpop-
ulation was stained according to Goodell et al. [19].
Briefly, cells were resuspended in preheated IMDM
medium (1-2 106 cells per 1 mL of IMDM). Hoechst
33342 (Honeywell Riedel-de Ha€en, Seezle, Germany)
was added to a final concentration of 5 mg/mL and
the suspension was incubated for exactly 90 minutes
at 37C. Afterward, the cells were washed with ice-
cold PBS/BSA and stained for specific surface markers
of LSK and SLAM cells with fluorescein-conjugated
monoclonal antibodies (20 min on ice and in the
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Gladbach, Germany), anti-Sca-1-APC, anti-cKit-
APC-Cy7, anti-CD150-PE, and anti-CD48-FITC
(BioLegend, San Diego, CA). After washing with
PBS/BSA, cells were incubated with streptavidin-PE-
Cy7 antibody for 15 minutes on ice in the dark and
washed again. Finally, they were resuspended in 200
mL PBS/BSA and analyzed via flow cytometry (BD
FACSAria II equipped withUV-laser, Becton-Dickin-
son, San Jose, CA). Doublets and debris were discrim-
inated and LSK SP and LSK SLAM populations were
gated (Supplementary Figure 1).
Viability and Apoptosis of LSK Cells
BM cells were stained for LSK markers. Hoechst
33342 and propidium iodide (PI; Sigma-Aldrich
Corp.) staining was used to distinguish apoptotic and
dead cells [20].Doublets and debris were discriminated
and live (Hoechst 33342 negative, PI negative), apo-
ptotic (Hoechst 33342 positive, PI negative), and
dead (Hoechst 33342 positive, PI positive) cells were
gated inside the population of nucleated BM cells and
inside the LSK population (Supplementary Figure 2).
GM-CFC Determination
Cells were cultivated in IMDM containing 0.3%
agar (Bactoagar, Difco Laboratories, Detroit, MI)
and 20% fetal calf serum (FCS) on 30-mm Petri dishes
in triplicate. Murine postendotoxin lung conditioned
medium (10%), prepared according to Burgess et al.
[21], was used as a source of colony stimulating factors.
Colonies of more than 50 cells were counted under the
microscope after 7 days.
CFU-S Determination
CFU-S were determined using the spleen colony
technique [22]. Groups of 10 recipient mice were
lethally irradiated with 9 Gy from a 60Co source. After
appropriate dilution in PBS/BSA, BM cells wereFigure 1. Engraftment of STRC and LTRC from cadaveric BM in sublethally
Ly5.1-positive cells (mean) detected by flow cytometry in peripheral blood of L
rism of donor cells transplanted after 0 (CTRL) to 5 hours of ischemia at 37C (A
ischemia at 4C (C). Recipients were irradiated with 6 Gy and i.v. transplanted
ANOVA with Dunnett’s post test was used to determine the statistical signific
each group (n 5 5) at individual time points (0.5, 1, 2, 3, 4, 5, and 6 months sinjected intravenously to irradiated mice and the
spleen colonies were counted after 8 days. The mean
colony numbers were corrected for colony overlap as
described previously [23].
Competitive Repopulation Assay
Fresh, cadaveric or in vitro stored BM cells from
Ly5.1 donors were transplanted to sublethally (6 Gy)
or lethally (9 Gy) irradiated (60Co) congenic Ly5.2 re-
cipient mice. Sublethally irradiated recipients were
transplanted with BM cells from half of the femur
(approximately 1  107 cells). Lethally irradiated re-
cipients were transplanted with a 1:1 ratio mixture of
cadaveric congenic (Ly5.1) and fresh syngenic
(Ly5.2) BM cells from half of the femur of each donor.
The expected chimerism was 50% in this case.
A single-cell suspension of BM cells was administered
intravenously through the retrobulbar plexus in a vol-
ume of 0.5 mL PBS/BSA. Five to 10 recipient mice
were used per group.
The engraftment of donor cells was determined
from peripheral blood 2 weeks after transplantation
and then at monthly intervals up to 6 months to distin-
guish the short-term repopulating cells (STRC) and
long-term repopulating cells (LTRC). Heparinized
blood samples of approximately 50 mL were collected
through the retrobulbar plexus puncture. Subse-
quently, erythrocytes were lysed for 15 minutes at
37C with 3 mL of ammonium chloride buffer. Sam-
ples were then washed and stained with phycoerythrin
(PE) conjugated anti-Ly5.1 and fluorescence isothio-
cyanate (FITC) conjugated anti-Ly5.2 antibodies
(BioLegend, SanDiego,CA).Chimerism (percentage of
donor derived cells) was determined by flow cytometry
(FACS Canto, Becton-Dickinson, Franklin Lakes, NJ).
Statistical Analysis
Statistical analysis was performed with GraphPad
Prism version 5.00 for Windows (GraphPad Software,irradiated recipients. Donor chimerism is presented as a percentage of
y5.2 recipients 14 days after BMTand then at monthly intervals. Chime-
), 0 (CTRL) to 20 hours of ischemia at 20C (B), 0 (CTRL) to 48 hours of
with BM cells in an amount corresponding to half of the femur. One-way
ance (***P\.005, **P\.01, *P\.05) comparing the chimerism level of
ince BMT) to the control.
Figure 2. Engraftment of STRC and LTRC from cadaveric BM cotransplanted with fresh congenic BM in lethally irradiated recipients (expected
chimerism 50%). Donor chimerism is presented as a percentage of Ly5.1-positive cells (mean) detected by flow cytometry in peripheral blood of
Ly5.2 recipients 14 days after BMT and then at monthly intervals. Chimerism of donor cells transplanted after 0 (CTRL) to 5 hours of ischemia at
37C (A), 0 (CTRL) to 20 hours of ischemia at 20C (B), 0 (CTRL) to 48 hours of ischemia at 4C (C). Recipients were irradiated with 9 Gy and i.v.
transplanted with a 1:1 mixture of cadaveric and fresh congenic BM. One-way ANOVA with Dunnett’s post test was used to determine the statistical
significance (***P\.005, **P\.01, *P\.05) comparing the chimerism level of each group (n5 5) at individual time points (0.5, 1, 2, 3, 4, 5, and 6 months
since BMT) to the control.
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presented as the mean in XY graphs and as the
mean 6 SEM in column graphs. One-way analysis of
variance (ANOVA) using Dunnett’s post test was used
to compare each group to the control was applied.
P values\ .05 were considered statistically significant.RESULTS
Engraftment of STRC and LTRC fromCadaveric
BM in Sublethally Irradiated Recipients
Figure 1 presents the percentage of donor cells in
the peripheral blood of recipients until 6 months afterFigure 3. Survival of CFU-S in cadaveric BM after 0 (CTRL) to 5 hours
of ischemia at 37C. Recipients were irradiated with 9 Gy and i.v. trans-
planted with BM cells in an amount corresponding to 1/200 of the femur.
Spleen colonies were counted 8 days later. Data are presented as
mean 6 SEM. One-way ANOVA with Dunnett’s post test was used to
determine the statistical significance (***P\.005, *P\.05) comparing
the colony numbers of each group (n 5 5) to the control.transplantation. At 37C (Figure 1A), transplantability
was not decreased by at least 2 hours of ischemia
(STRC) and 3 hours of ischemia (LTRC). At 20C
(Figure 1B), engraftment was comparable to the con-
trol for up to 6 hours of ischemia. A 20-hour-long
ischemia at 20C resulted in a complete loss of engraft-
able cells. At 4C (Figure 1C), engraftment was not
significantly decreased by up to 12 hours of ischemia
and a reduced engraftment was still present after
24 hours of ischemia.
Engraftment of STRC and LTRC fromCadaveric
BM Cotransplanted with Fresh Congenic BM in
Lethally Irradiated Recipients (Expected
Chimerism 50%)
The chimerism of Ly5.1 donor cells in the periph-
eral blood of recipients is shown in Figure 2. At 37C
(Figure 2A), the engraftment of ischemic cells with up
to 2 hours of ischemia was comparable to that of their
nonaffected counterparts. At 20C (Figure 2B), cells
ischemic for up to 3 hours successfully competed
with fresh ones in the short- and long-term repopula-
tion and those up to 12 hours in the long-term repopu-
lation. At 4C (Figure 2C), there was still a significant
(about 30%) engraftment even when the ischemia
lasted for 48 hours.
Survival of CFU-S in Cadaveric BM
The influence of ischemia at 37C on CFU-S (rep-
resenting hematopoietic progenitor cells) is shown in
Figure 3. There was already a significant decrease after
1 hour of ischemia and after 3 hours, CFU-S were
almost completely lost.
Survival of Cells in Cadaveric BM
The cellularity of BM was (18.5 6 0.69)  106
(mean 6 SEM) cells per femur and it did not decrease
significantly during the periods of ischemia (Figure 4).
Figure 4. Survival of cells in cadaveric BM. Cellularity of the femur and percentage of live, apoptotic and dead cells in BM after 0 (CTRL) to 5 hours of
ischemia at 37C (A), 0 (CTRL) to 20 hours of ischemia at 20C (B), 0 (CTRL) to 48 hours of ischemia at 4C (C). Bone marrow cells were stained with
Hoechst 33342 and propidium iodide and analyzed by flow cytometry. Data are presented as mean (n5 3). Average cellularity of the femur was (18.56
0.69)  106 and there was no decrease caused by ischemia in the number of cells during the studied time periods.
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ischemia is also presented in Figure 4. After 2 hours at
37C, BM contained about 50% apoptotic and dead
cells and this number increased to 90%within 5 hours.
At 20C, the same survival ratio was observed after
6 hours and 20 hours, respectively, and after 48 hours
at 4C, live cells still constituted more than 10% of the
cells in the BM.Survival of LSK Cells in Cadaveric BM
Figure 5 shows the percentage of LSK cells
(LinlowSca-11c-Kit1) in cadaveric BM and the amount
of live, apoptotic, and dead cells in this subpopulation.
For as long as the LSK phenotype lasted, more live and
less apoptotic and dead cells were detected in this pop-
ulation than in the BM as a whole at all monitored tem-
peratures (37C, 20C, 4C).Figure 5. Survival of LSK cells in cadaveric BM. Percentage of live, apoptotic, an
0 (CTRL) to 20 hours of ischemia at 20C (B), 0 (CTRL) to 48 hours of ischem
Hoechst 33342 and propidium iodide and analyzed by flow cytometry. Data ar
was used to determine the statistical significance (***P\.005, **P\.01, *P\LSK SLAM and LSK SP Cells in Cadaveric BM
The percentage of LSK SLAM (LSK
CD1501CD482) and LSK SP (side population,
Hoechst 33342 negative) cells in BM after various pe-
riods of ischemia at 37C, 20C, and 4C is presented
in Figure 6. At 37C, the LSK SP percentage was sig-
nificantly decreased after 1 hour of ischemia and after
3 hours, the side population was no longer detectable;
the LSK SLAM number remained unchanged after
3 hours of ischemia. At 20C and 4C, the LSK SP
and LSK SLAM populations were lost after 12 hours
and 48 hours of ischemia, respectively.
Engraftment of STRC and LTRC from In Vitro
Stored BM in Sublethally Irradiated Recipients
The chimerism resulting from the transplantation
of in vitro stored BM cells is shown in Figure 7.d dead LSK cells in BM after 0 (CTRL) to 5 hours of ischemia at 37C (A),
ia at 4C (C). Bone marrow cells were stained for LSK markers and with
e presented as mean (n5 3). One-way ANOVA with Dunnett’s posttest
.05) comparing the percentage of LSK cells in each group to the control.
Figure 6. LSK SLAM and LSK SP cells in cadaveric BM. Percentage of LSK SLAM and LSK SP cells after 0 (CTRL) to 5 hours of ischemia at 37C (A),
0 (CTRL) to 12 hours of ischemia at 20C (B), 0 (CTRL) to 48 hours of ischemia at 4C (C). Bone marrow cells were stained for LSK markers, SLAM
markers, and with Hoechst 33342 to detect SP population and analyzed by flow cytometry. Data are presented as mean 6 SEM (n 5 3). One-way
ANOVA with Dunnett’s post test was used to determine the statistical significance (**P\.01, *P\.05) comparing the percentage of LSK SLAM and
LSK SP cells in each group to the control.
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specific hematopoietic growth factors for up to 2
days at 37C and for up to 4 days at 4C did not signif-
icantly affect the chimerism compared to that resulting
from transplantation of fresh BM cells in the control
group.Survival of BM Cells, GM-CFC, and CFU-S in
In Vitro Suspension
The survival of BM cells in a cell culturemedium at
37C and 4C is shown in Figure 8. At 37C, their via-
bility decreased rapidly over the first 4 days (Figure 8A).
At 4C, there was no significant difference in theFigure 7. Engraftment of STRC and LTRC from in vitro stored bone
marrow in sublethally irradiated recipients. Donor chimerism is pre-
sented as a percentage of Ly5.1-positive cells (mean) detected by flow
cytometry in peripheral blood of Ly5.2 recipients 14 days after BMT
and then at monthly intervals. Recipients were irradiated with 6 Gy
and i.v. transplanted with BM cells in an amount corresponding to half
of the femur. Cells were transplanted at day 0 (CTRL), after 1 and 2
days of in vitro storage at 37C and after 2 and 4 days of in vitro storage
at 4C. One-way ANOVA with Dunnett’s post test was used to deter-
mine the statistical significance (all values were nonsignificant) compar-
ing the chimerism level of each group (n 5 5) at individual time points
(0.5, 1, 2, 3, 4, 5, and 6 months since BMT) to the control.viability of incubated cells. After 10 days, the number
of live cells was approximately 70% (Figure 8B).
The survival of hematopoietic progenitor cells was
evaluated via GM-CFC and CFU-S assays. At 37C,
the viability of both GM-CFC and CFU-S was de-
creased after 1 day of in vitro storage (Figure 8C). At
4C, the viability of GM-CFC and CFU-S was main-
tained for 1 day and 3 days, respectively (Figure 8D).DISCUSSION
Stem cells can be a source of tissue regeneration af-
ter various kinds of tissue damage. As such, they should
be among the most resistant cells when the tissue is ex-
posed to unfavorable conditions. Hematopoietic stem
cells are slow cycling (dormant) cells residing in hyp-
oxic regions of the BM [12,24]. Because of their
relative proliferative and metabolic quiescence,
significant tolerance to a critical shortage of oxygen
and energy supply (eg, postmortem) might be
assumed. However, in a few studies exploring the use
of cadaveric BM as a source of HSPC for
transplantation, BM cells were always harvested
immediately after the cessation of circulation and
their functioning was studied in vitro [3,4,25,26].
The possibility of a delayed harvesting of BM for
transplantation has not been explored to our
knowledge. In this study, the influence of extended
ischemia at various temperatures was investigated as
well as of in vitro storage of the cells in a suspension
on the phenotype and functional characteristics of
murine BM cells and HSPC. The investigation
included functional tests of HSPC properties,
namely, competitive repopulation assay, clonogenic
assay, and flow cytometry analysis, using a murine
experimental model. BM ischemia was modeled in
intact femurs after removal from the body. An
experiment comparing the effect of when the
Figure 8. Survival of BM cells, GM-CFC, and CFU-S in a suspension in vitro. Survival is presented as a percentage of control. Data are presented as
mean 6 SEM. Percentage of live BM cells after 0 (CTRL) to 7 days of in vitro storage at 37C (A), 0 (CTRL) to 10 days of in vitro storage at 4C (B),
survival of GM-CFC and CFU-S after 0 (CTRL) to 3 days of in vitro storage at 37C (C), 0 (CTRL) to 7 days of in vitro storage at 4C. One-way ANOVA
with Dunnett’s post test was used to determine the statistical significance (***P\.005, **P\.01, *P\.05) comparing the viability of each group (n5 6)
to the control.
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chemia proved that after 3 hours at 37C, there was no
significant difference in the declines of LSK SLAM
and LSK SP cells in the BM (Supplementary Figure 3).
Our results demonstrate that murine HSPC sur-
vive ischemia for a considerable length of time, even
when the temperature of the BM is maintained at
37C. The repopulating ability of HSPC kept in fe-
murs at 37C and harvested 2 hours postmortem was
fully preserved. At 20C and 4C, this period was
significantly extended (Figure 1 and Figure 2). These
results are in agreement with the cytometric determi-
nation of LSK SLAM and LSK SP cell numbers.
The percentage of LSK SLAM cells was not signifi-
cantly decreased in cadaveric BM as long as its trans-
plantability was maintained (Figure 6). This was also
true of LSK SP cells, except for at 37C, when the
number of LSK SP decreased rapidly (Figure 6).This decline could be because of a lack of energy for
the ATP-dependent ABCG2 transporter, which ef-
fluxes the dye from SP cells [27], whereas the other
functional properties of HSPC were maintained for
a prolonged period of time. These results show that
most of the stem cell phenotype used for their detec-
tion by flow cytometry is preserved in cadaveric BM
in parallel with their transplantability.
Hematopoietic progenitors, detected as CFU-S
(Figure 3) as well as STRC up to 1 month after
BMT (Figure 1), were more susceptible to damage
by ischemia than LTRC. This is in agreement with
their higher proliferation and likely metabolic activity
[28,29].
Nevertheless, both hematopoietic stem and pro-
genitor cells survived ischemia better than the differ-
entiated precursors of blood cells present in the BM.
There was a lower fraction of apoptotic and dead cells
1280 Biol Blood Marrow Transplant 17:1273-1281, 2011J. Michalova et al.in the LSK population than in the overall population
of BM cells until the LSK markers were no longer de-
tectable (Figure 4 and Figure 5). LSK cells represent
a fraction of BM cells highly enriched in HSPC, which
are slow cycling. Because .50% of differentiated
blood precursor cells proliferate actively [29], the re-
sult appears to reflect a particular proliferation rate.
This explanation is also supported by the decline in
proliferating CFU-S [28], which roughly correlated
to the increase number of dead and apoptotic BM cells.
In addition, we examined the tolerance ofHSPC to
unfavorable conditions in vitro, when BM cells were
stored in a medium with fetal bovine serum but with-
out specific growth factors added. The impact of
a short-term (several-day) liquid storage on BM cells
has already been described in previous studies, focused
on its viability and stem cell recovery [30], clonogenic
potential [3,25], kinetics of apoptosis, and production
of reactive oxygen species [4], and also on the engraft-
ment potential of HSPC [31,32]. These studies con-
firm that the storage of BM cells at 4C preserves the
clonogenic and engraftment potential of HSPC from
overnight storage [31,32] up to 1 week [4].
In this study, HSPC stored in vitro in a suspension
of BM cells survived for a significantly longer period
than those left in situ under ischemic conditions. Com-
petitive transplantation of these cells to sublethally irra-
diated hosts demonstrated a preserved transplantability
of bothSTRCandLTRCfor at least 2 days of storage at
37C and 4 days of storage at 4C (Figure 7).
As for GM-CFC and CFU-S, a significant de-
crease in the viability of these progenitors was detected
as early as after 1 day of storage in a suspension at 37C
(Figure 8). At 4C, CFU-S survived up to 3 days,
whereas GM-CFC only maintained full viability for
1 day. This is in agreement with the fact that these cells
proliferate actively [28], and GM-CFC are more
mature than CFU-S [33,34]. Hence, a temperature of
4C can be recommended for short-term HSPC
storage in a suspension before transplantation or
cryopreservation.
Although our findings were obtained from a mu-
rine model, similar overall patterns of behavior could
also be envisaged for human HSPC. However, for ex-
panding the donor pool of human hematopoietic stem
cells, the presented results should be verified with hu-
man tissue and specific conditions for optimal storage
of cadaveric human cells will need to be determined.
In conclusion, our study demonstrates that hema-
topoietic stem cells survive in murine cadaveric BM
for 3 to 12 hours depending on the temperature. Ca-
daveric BM was proven to be able to restore damaged
hematopoiesis in myeloablated mice. Nevertheless, it
is recommended to collect HSPC as soon as possible
and to store them in a medium even without specific
growth factors where they survive better than those
left in situ in a structurally intact BM. Cooling BMcells to 4C significantly preserves the long-term repo-
pulation ability of hematopoietic stem cells in cadav-
eric BM in situ as well as in a culture medium in vitro.ACKNOWLEDGMENTS
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